74 related articles for article (PubMed ID: 23098686)
1. Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.
Bjermer L; Bengtsson T; Jorup C; Lötvall J
Respir Med; 2013 Jan; 107(1):84-90. PubMed ID: 23098686
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E
Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737
[TBL] [Abstract][Full Text] [Related]
3. Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies.
Jorup C; Bengtsson T; Strandgården K; Sjöbring U
BMC Pulm Med; 2014 Mar; 14():52. PubMed ID: 24669829
[TBL] [Abstract][Full Text] [Related]
4. Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD.
Gelb AF; Fraser C; Zamel N
Respir Med; 2011 May; 105(5):755-60. PubMed ID: 21159499
[TBL] [Abstract][Full Text] [Related]
5. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.
Decramer M; Celli B; Tashkin DP; Pauwels RA; Burkhart D; Cassino C; Kesten S
COPD; 2004; 1(2):303-12. PubMed ID: 17136995
[TBL] [Abstract][Full Text] [Related]
7. Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide.
Verbanck S; Schuermans D; Vincken W
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):625-34. PubMed ID: 18268937
[TBL] [Abstract][Full Text] [Related]
8. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD.
Hasegawa M; Makita H; Nasuhara Y; Odajima N; Nagai K; Ito Y; Betsuyaku T; Nishimura M
Thorax; 2009 Apr; 64(4):332-8. PubMed ID: 19074932
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease.
Wang T; Luo G; Hu Y; Li F; Ma J; Wang J; Zuo P; Xiong W; Liu X; Zhao J; Xiong S; Zhang Z; Li C; Zhao S; Sun J; Xu Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):614. PubMed ID: 22038349
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: a systematic review.
Rodrigo GJ; Plaza V; Castro-Rodríguez JA
Pulm Pharmacol Ther; 2012 Feb; 25(1):40-7. PubMed ID: 22085775
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.
Criner GJ; Sharafkhaneh A; Player R; Conoscenti CS; Johnson P; Keyser MT; Cassino C
COPD; 2008 Feb; 5(1):35-41. PubMed ID: 18259973
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease.
Chan CK; Maltais F; Sigouin C; Haddon JM; Ford GT;
Can Respir J; 2007; 14(8):465-72. PubMed ID: 18060091
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease.
Singh D; Ravi A; Kane K; Schmalbach T; Hava DL
Br J Clin Pharmacol; 2018 Sep; 84(9):2097-2105. PubMed ID: 29790581
[TBL] [Abstract][Full Text] [Related]
14. Eletrocardiographic monitoring in COPD patients receiving tiotropium.
Morganroth J; Golisch W; Kesten S
COPD; 2004; 1(2):181-90. PubMed ID: 17136986
[TBL] [Abstract][Full Text] [Related]
15. Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children.
Teixeira MFC; Rodrigues JC; Leone C; Adde FV
Chest; 2013 Sep; 144(3):974-980. PubMed ID: 23558666
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled tiotropium on left ventricular diastolic function in chronic obstructive pulmonary disease patients after pulmonary resection.
Nojiri T; Yamamoto K; Maeda H; Takeuchi Y; Funakoshi Y; Maekura R; Okumura M
Ann Thorac Cardiovasc Surg; 2012; 18(3):206-11. PubMed ID: 22790991
[TBL] [Abstract][Full Text] [Related]
17. The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD.
Hasani A; Toms N; Agnew JE; Sarno M; Harrison AJ; Dilworth P
Chest; 2004 May; 125(5):1726-34. PubMed ID: 15136383
[TBL] [Abstract][Full Text] [Related]
18. Use of tiotropium bromide for pre-operative treatment in chronic obstructive pulmonary disease patients: comparison with oxitropium bromide.
Matsuyama W; Mitsuyama H; Koreeda Y; Higashimoto I; Osame M; Arimura K
Intern Med; 2007; 46(17):1373-9. PubMed ID: 17827835
[TBL] [Abstract][Full Text] [Related]
19. [After diagnosis 11 more years remain. COPD alarm in Europe!].
Wepner U
MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590
[No Abstract] [Full Text] [Related]
20. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease.
Disse B; Speck GA; Rominger KL; Witek TJ; Hammer R
Life Sci; 1999; 64(6-7):457-64. PubMed ID: 10069510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
